The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Tata Motors, Nykaa, Ola Electric, Hi-Tech Pipes, and More - Heres a quick recap of stocks that are likely to attract ...

GSK Australia Media ReleaseIncreasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

Increasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits every year, according to a new report commissioned ...

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for ...

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

One month after taking the vaccine, participants developed at least four times increase in levels of neutralizing antibodies for the two primary types of RSV. The news comes as Pfizer is trying to ...

The latest health news includes challenges faced by Gazan mothers in war-torn areas, U.S. bird flu vaccine expansions, ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...